Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

The research found that specific stem cells maintain skin gland openings and that disrupting their activity can cause blockages or early cancer signs, indicating a need for targeted treatments.

The treatment was ineffective in humans.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Computational methods help design drugs targeting prostate cancer proteins.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

Mitochondrial activity varies in cells before they stop growing, affecting their growth potential.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Certain substances that block a specific protein help promote hair growth.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.